CY1109549T1 - Μεθοδος καταπολεμησης λοιμωξης - Google Patents

Μεθοδος καταπολεμησης λοιμωξης

Info

Publication number
CY1109549T1
CY1109549T1 CY20091101129T CY091101129T CY1109549T1 CY 1109549 T1 CY1109549 T1 CY 1109549T1 CY 20091101129 T CY20091101129 T CY 20091101129T CY 091101129 T CY091101129 T CY 091101129T CY 1109549 T1 CY1109549 T1 CY 1109549T1
Authority
CY
Cyprus
Prior art keywords
infection
tretazicar
host organism
spp
parasitic
Prior art date
Application number
CY20091101129T
Other languages
English (en)
Inventor
Philip John Burke
Roger Melton
Richard John Knox
Original Assignee
Morvus Technology Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Morvus Technology Ltd. filed Critical Morvus Technology Ltd.
Publication of CY1109549T1 publication Critical patent/CY1109549T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/396—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having three-membered rings, e.g. aziridine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

Μέθοδος καταπολέμησης μιας παρασιτικής πρωτοζωικής λοίμωξης ενός ξενιστή οργανισμού, η δε μέθοδος περιλαμβάνει χορήγηση τρεταζικάρης στον οργανισμό ξενιστή. Η τρεταζικάρη είναι η ένωση 5-(αζιριδιν-1-υλ)-2,4-δινιτροβενζαμίδιο (CB 1954) και η παρασιτική λοίμωξη κατά προτίμηση είναι μία λοίμωξη του Trypanosoma cruzi, T.b. brucei, Leismania spp., ιδιαιτέρως L. Infantum, Cryptosporidium ή Giardia spp.
CY20091101129T 2005-09-03 2009-10-29 Μεθοδος καταπολεμησης λοιμωξης CY1109549T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0517957.7A GB0517957D0 (en) 2005-09-03 2005-09-03 Method of combating infection
EP06779273A EP1933829B1 (en) 2005-09-03 2006-09-04 Method of combating infection

Publications (1)

Publication Number Publication Date
CY1109549T1 true CY1109549T1 (el) 2014-08-13

Family

ID=35220805

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20091101129T CY1109549T1 (el) 2005-09-03 2009-10-29 Μεθοδος καταπολεμησης λοιμωξης

Country Status (17)

Country Link
US (1) US8415334B2 (el)
EP (1) EP1933829B1 (el)
CN (1) CN101282723B (el)
AR (1) AR055409A1 (el)
AT (1) ATE437638T1 (el)
BR (1) BRPI0615448A2 (el)
CA (1) CA2620398C (el)
CY (1) CY1109549T1 (el)
DE (1) DE602006008162D1 (el)
DK (1) DK1933829T3 (el)
EC (1) ECSP088328A (el)
ES (1) ES2356330T3 (el)
GB (1) GB0517957D0 (el)
MY (1) MY144154A (el)
PL (1) PL1933829T3 (el)
PT (1) PT1933829E (el)
WO (1) WO2007026166A2 (el)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0526552D0 (en) 2005-12-29 2006-02-08 Morvus Technology Ltd New use
GB2442202A (en) 2006-09-30 2008-04-02 Morvus Technology Ltd Vermin poison
US9173898B2 (en) 2010-10-12 2015-11-03 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Methods of treating giardiasis

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3208999A (en) * 1964-09-09 1965-09-28 Nat Starch Chem Corp Preparation of non-inhibited starch amines
US3658788A (en) * 1969-06-06 1972-04-25 Salk Inst For Biological Studi Aminooxazolines and products thereof and processes for synthesizing same
CA1089763A (en) * 1978-10-30 1980-11-18 Willard J. Johnson Rodenticide comprising 6-aminonicotinamide and 6- aminonicotinohydroxamic acid
CS204501B1 (en) 1978-11-06 1981-04-30 Miroslav Dub Shaped trap for regulation of the numbers of exoantropous and hemisynantropous rodents classes
US4375394A (en) * 1982-03-11 1983-03-01 Eastman Kodak Company Electrolytic process for the preparation of ethylene glycol and glycerine
GB8705477D0 (en) 1987-03-09 1987-04-15 Carlton Med Prod Drug delivery systems
GB8804068D0 (en) 1988-02-22 1988-03-23 Roberts J R Improvements relating to control of neoplastic tissue growth
CH680180B5 (el) * 1988-07-29 1993-01-15 Ciba Geigy Ag
DE3833194A1 (de) 1988-09-30 1990-04-05 Basf Ag Verfahren zum faerben von textilen materialien aus cellulosefasern
DE4103639A1 (de) 1991-02-07 1992-08-13 Basf Ag Verfahren zum faerben von textilen materialien aus cellulosefasern
EP0540263A1 (en) * 1991-10-23 1993-05-05 Cancer Research Campaign Technology Limited Bacterial nitroreductase for the reduction of CB 1954 and analogues thereof to a cytotoxic form
GB9412394D0 (en) 1994-06-21 1994-08-10 Danbiosyst Uk Colonic drug delivery composition
DE4425436A1 (de) * 1994-07-19 1996-01-25 Basf Ag Verfahren zur Herstellung von Acyloinen
GB9415167D0 (en) 1994-07-27 1994-09-14 Springer Caroline J Improvements relating to cancer therapy
US5632782A (en) * 1994-09-01 1997-05-27 Clariant Finance (Bvi) Ltd. Exhaust dyeing process for sulphur dyes
US20040053208A1 (en) 1995-08-29 2004-03-18 V. I. TECHNOLOGIES, Inc. Methods to selectively inactivate parasites in biological compositions
AU1166097A (en) 1995-12-21 1997-07-17 British Technology Group Limited Indoloquinone derivatives as bioreductive agents
ATE247984T1 (de) 1997-02-11 2003-09-15 Univ Manchester Bioreduktive konjugate zur gezielten wirkstoffzufuhr
GB9710699D0 (en) 1997-05-24 1997-07-16 Danbiosyst Uk Gastro-retentive controlled release system
GB9712370D0 (en) 1997-06-14 1997-08-13 Aepact Ltd Therapeutic systems
GB2365338B (en) 1997-06-14 2002-04-03 Enzacta R & D Ltd Therapeutic systems
US6159706A (en) 1997-12-23 2000-12-12 Newbiotics, Inc. Application of enzyme prodrugs as anti-infective agents
CA2332806A1 (en) 1998-05-22 1999-12-02 Natalie Dales Bioreductive cytotoxic agents
WO2000010611A2 (en) 1998-08-19 2000-03-02 The Victoria University Of Manchester Drug targeting
MXPA02008637A (es) 2000-03-02 2004-09-06 Ml Lab Plc Elemento de respuesta a factor de celulas t.
DE10049468A1 (de) 2000-10-06 2002-04-11 Bayer Ag N-Alkoxyalkyl-substituierte Benzimidazole, ihre Herstellung und ihre Verwendung als Mittel gegen parasitäre Protozoen
US20030228285A1 (en) * 2002-05-03 2003-12-11 Mien-Chie Hung Bipartite T-cell factor (Tcf)-responsive promoter
GB0223696D0 (en) 2002-10-14 2002-11-20 Ml Lab Plc Improved immunotherapy
CA2570245A1 (en) 2004-07-02 2006-01-12 Warner-Lambert Company Llc Compositions and methods for treating pathological infections

Also Published As

Publication number Publication date
WO2007026166A2 (en) 2007-03-08
EP1933829A2 (en) 2008-06-25
EP1933829B1 (en) 2009-07-29
CA2620398C (en) 2010-11-30
DE602006008162D1 (de) 2009-09-10
AR055409A1 (es) 2007-08-22
CN101282723A (zh) 2008-10-08
ATE437638T1 (de) 2009-08-15
WO2007026166A3 (en) 2007-06-28
DK1933829T3 (da) 2009-11-30
CA2620398A1 (en) 2007-03-08
MY144154A (en) 2011-08-15
US20100273762A1 (en) 2010-10-28
CN101282723B (zh) 2012-06-13
PT1933829E (pt) 2009-11-04
GB0517957D0 (en) 2005-10-12
US8415334B2 (en) 2013-04-09
PL1933829T3 (pl) 2010-01-29
ES2356330T3 (es) 2011-04-07
ECSP088328A (es) 2008-08-29
BRPI0615448A2 (pt) 2011-05-17

Similar Documents

Publication Publication Date Title
ATE471148T1 (de) Medizinische verwendung eines tetrahydrotriazoloä4,3-aüpyrazins
CY1106486T1 (el) Μεθοδος παρασκευης 2-(κινοξαλιν-5-υλσουλφονυλαμινο) βενζαμιδικων ενωσεων
BR0316107A (pt) N-alquil-4-metilenoamino-3-hidróxi-2-piridonas como antimicrobianos
DE60217432D1 (de) Verwendungen von Kohlenstofffasern
DE60315146D1 (de) Heteroarylsubstituierte biphenylderivate als inhibitoren von p38-kinase
DE60223841D1 (de) Medizinische verwendung von gsk3-hemmenden oxindolderivaten
EA200700119A1 (ru) Соединения и способы лечения дислипидемии
BR122012009534B8 (pt) 4-[2-(4-metil-fenil-sulfanil)-fenil]-piperidina, seu uso e composição farmacêutica compreendendo o referido composto
CY1108081T1 (el) Αρυλο-και ετεροαρυλο υποκατεστημενες τετραυδροισοκινολινες και χρησις αυτων προς αποκλεισμον επαναπροσληψεως νορεπινεφρινης ντοπαμινης και σεροτονινης
EA200700286A1 (ru) Применение замещённых производных 2-пирролидона в качестве фунгицидов и инсектицидов
CY1112780T1 (el) Νεα σουλφονυλοπυρρολια ως αναστολεις της ηdac
DE602004020156D1 (de) Verwaltung von Rahmenbursts
PA8571001A1 (es) 2-(2,6-diclorofenil)-diarilimidazoles
NO20054476L (no) Forbindelser for behandling av smerte
TW200510333A (en) Benzimidazole compounds
CY1106957T1 (el) Ν-σουλφονυλο-4-μεθυλεναμινο-3-υδροξυ-2-πυριδονες ως αντιμικροβιακοι παραγοντες
ATE413392T1 (de) Kondensierte heteroyralderivate und deren verwendung als p38-kinase-inhibitoren
CY1109549T1 (el) Μεθοδος καταπολεμησης λοιμωξης
EA200501226A1 (ru) Новая кристаллическая модификация негидратированного боскалида
NO20055750L (no) Nye kjemiske forbindelser
DE602004031410D1 (de) Inden derivate als pharmazeutika
ATE373645T1 (de) Phenyltetrazol-verbindungen
TW200609228A (en) Substituted n-acyl-2-aminothiazoles
EA200400117A1 (ru) Производные 6-[2-(фосфонометокси)алкокси]пиримидинов, обладающие антивирусной активностью, способ их получения (варианты) и способ лечения вирусной инфекции
DE60311887D1 (de) Multifunktionelle kationische photoinitiatoren, deren herstellung und verwendung